Noseda Alessandro 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed May 19, 2022
Insider Transaction Report
Form 4
Noseda Alessandro
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-17+240,000→ 240,000 totalExercise: $0.19Exp: 2032-05-17→ Common Stock (240,000 underlying)
Holdings
- 240,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2031-08-02→ Common Stock (240,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2029-05-15→ Common Stock (200,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.30Exp: 2030-06-10→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]50,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
- [F3]60,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
- [F4]120,000 shares vest on each of 5/17/22 and 5/17/23.